Macquarie Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Macquarie Group’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-440	Closed	-$23K	–	2399
2020 Q3	$23K	Hold	440	–	–	﹤0.01%	2146
2020 Q2	$27K	Sell	440 -2,360	-84%	-$137K	﹤0.01%	2098
2020 Q1	$158K	Hold	2,800	–	–	﹤0.01%	1516
2019 Q4	$159K	Sell	2,800 -1,800	-39%	-$95.4K	﹤0.01%	1672
2019 Q3	$246K	Hold	4,600	–	–	﹤0.01%	1529
2019 Q2	$275K	Buy	+4,600	New	+$289K	﹤0.01%	1506
2019 Q1	–	Sell	-100	Closed	-$6K	–	2219
2018 Q4	$6K	Sell	100 -100	-50%	-$5.97K	﹤0.01%	2079
2018 Q3	$12K	Hold	200	–	–	﹤0.01%	1978
2018 Q2	$9K	Buy	+200	New	+$8.6K	﹤0.01%	2131
2018 Q1	–	Sell	-779	Closed	-$34K	–	2477
2017 Q4	$34K	Sell	779 -800	-51%	-$36K	﹤0.01%	2068
2017 Q3	$73K	Buy	+1,579	New	+$75.6K	﹤0.01%	1968

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Macquarie Group's BSTC Position: Q4 2020 in Review

Macquarie Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 440 shares — an estimated $23K sold.

Macquarie Group first reported a position in BSTC in Q3 2017 and held it in 11 quarters. The position peaked at $275K in Q2 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Macquarie Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Macquarie Group sold 440 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $23K.
Macquarie Group first reported a position in BioSpecifics Technologies Corp. in Q3 2017 and held it in 11 quarters.
Macquarie Group's BioSpecifics Technologies Corp. position peaked at $275K in Q2 2019.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.